Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Fillit

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 24, 2023
Disease progression and costs at the 3-year follow-up of the GERAS-US studyJulie M Chandler, Dorene M Rentz, Anthony Zagar, et al.
Science of Aging Knowledge Environment : SAGE KE|June 30, 2006
From bedside to bench: does mental and physical activity promote cognitive vitality in late life?Stephanie Studenski, Michelle C Carlson, Howard Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
New directions for frontotemporal dementia drug discoveryJohn Q Trojanowski, Karen Duff, Howard Fillit, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approachesErika Bereczki, Francesca Mangialasche, Mariagnese Barbera, et al.
JMIR Public Health and Surveillance|August 4, 2020
Real-Time Digital Contact Tracing: Development of a System to Control COVID-19 Outbreaks in Nursing Homes and Long-Term Care FacilitiesGerald Wilmink, Ilyssa Summer, David Marsyla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Health economics and the value of therapy in Alzheimer's diseaseElias M Schwam, Susan Abu-Shakra, Megan del Valle, et al.
CNS Drugs|April 25, 2017
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical DataPetr Kocis, Martin Tolar, Jeremy Yu, et al.
Neurology and Therapy|August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's DiseaseWilliam L Herring, Ian Gopal Gould, Howard Fillit, et al.
Disease Management : DM|August 25, 2005
Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the medicare populationJerrold Hill, Janine M McVay, Adrian Walter-Ginzburg, et al.
International Journal of Geriatric Psychiatry|April 5, 2007
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's diseaseBengt Winblad, Ariane K Kawata, Kathleen M Beusterien, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 24, 2023
Disease progression and costs at the 3-year follow-up of the GERAS-US studyJulie M Chandler, Dorene M Rentz, Anthony Zagar, et al.
Science of Aging Knowledge Environment : SAGE KE|June 30, 2006
From bedside to bench: does mental and physical activity promote cognitive vitality in late life?Stephanie Studenski, Michelle C Carlson, Howard Fillit, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 18, 2008
New directions for frontotemporal dementia drug discoveryJohn Q Trojanowski, Karen Duff, Howard Fillit, et al.
The Journal of Prevention of Alzheimer'S Disease|October 27, 2025
Risk reduction and precision prevention across the Alzheimer's disease continuum: a systematic review of clinical trials combining multidomain lifestyle interventions and pharmacological or nutraceutical approachesErika Bereczki, Francesca Mangialasche, Mariagnese Barbera, et al.
JMIR Public Health and Surveillance|August 4, 2020
Real-Time Digital Contact Tracing: Development of a System to Control COVID-19 Outbreaks in Nursing Homes and Long-Term Care FacilitiesGerald Wilmink, Ilyssa Summer, David Marsyla, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Health economics and the value of therapy in Alzheimer's diseaseElias M Schwam, Susan Abu-Shakra, Megan del Valle, et al.
CNS Drugs|April 25, 2017
Elucidating the Aβ42 Anti-Aggregation Mechanism of Action of Tramiprosate in Alzheimer's Disease: Integrating Molecular Analytical Methods, Pharmacokinetic and Clinical DataPetr Kocis, Martin Tolar, Jeremy Yu, et al.
Neurology and Therapy|August 24, 2021
Predicted Lifetime Health Outcomes for Aducanumab in Patients with Early Alzheimer's DiseaseWilliam L Herring, Ian Gopal Gould, Howard Fillit, et al.
Disease Management : DM|August 25, 2005
Validation of a brief screen for cognitive impairment (BSCI) administered by telephone for use in the medicare populationJerrold Hill, Janine M McVay, Adrian Walter-Ginzburg, et al.
International Journal of Geriatric Psychiatry|April 5, 2007
Caregiver preference for rivastigmine patch relative to capsules for treatment of probable Alzheimer's diseaseBengt Winblad, Ariane K Kawata, Kathleen M Beusterien, et al.
Pageof 8